Requirements, expectations, challenges and opportunities associated with training the next generation of pharmacometricians-Reference-Cited by-同舟云学术

Requirements, expectations, challenges and opportunities associated with training the next generation of pharmacometricians

Published:2023-05-02 Issue:7 Volume:12 Page:883-888
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacom & Syst Pharma

Author:

Schmidt Stephan¹^ORCID,Vozmediano Valvanera¹^ORCID,Cristofoletti Rodrigo¹,Kim Sarah¹^ORCID,Lin Zhoumeng²,de Moraes Natalia¹^ORCID,Azeredo Francine¹,Cicali Brian¹,Leuenberger Hans¹,Brown Joshua D.³,Jin Jin Y.⁴^ORCID,Musante Cynthia J.⁵^ORCID,Tannenbaum Stacey⁶,Wang Yaning⁷

Affiliation:

1. Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy University of Florida Orlando Florida USA

2. Department of Environmental and Global Health, College of Public Health and Health Professions University of Florida Gainesville Florida USA

3. Department of Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety, College of Pharmacy University of Florida Gainesville Florida USA

4. Clinical Pharmacology Genentech, Inc. South San Francisco California USA

5. Pfizer Worldwide Research Development and Medical Cambridge Massachusetts USA

6. Pharmacometrics US Astellas Pharma Northbrook Illinois USA

7. Createrna Science and Technology Shanghai China

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12970

Reference10 articles.

1. Perspective on model‐informed drug development

2. Model‐Informed Drug Development: Current US Regulatory Practice and Future Considerations

3. Clinical pharmacology, creating current and future success in drug development

4. Pharmacometrics: A Multidisciplinary Field to Facilitate Critical Thinking in Drug Development and Translational Research Settings

5. Should Pharmacometrics Be Training the Next R&D President?